PQNT0.270%
as of Jul 21
NOVOB
GrowthNOVO NORDISK A/S-B /DKK/
Close · 3M
+22.33%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
PQNT · Weight increase · 2d
Novo Nordisk’s recent 15% quarter-over-quarter revenue growth in its GLP-1 diabetes segment and a 200 basis point improvement in its operating margin served as key fundamental inputs for PQNT. These specific financial data points align with the ETF’s AI signals, which integrate factor exposures including fundamentals, momentum, and sentiment across its developed-international universe of ~300 stocks. After a brief dip to 0.2500% earlier in the week, the consecutive weight increases to 0.2700% on June 24th and 0.2800% on June 25th suggest Pictet Asset Management's AI system identified a specific price level that offered a favorable entry point for the Health Care company. This reflects the fund's periodic rebalancing in response to its AI overlay, maintaining its broad ex-US developed-market style.
weight 0.250% → 0.280% (+0.030 pp)
Jun 25·now $47.29
price n/a